{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:41:42Z","timestamp":1780440102764,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The development of scleritis in the setting of autoimmune conditions has been well documented. Prior series have assessed the relationship between systemic autoimmune disorders and scleritis only in patients referred for rheumatologic or ocular inflammation. This can lead to a referral bias. We reviewed all charts within the electronic medical record (EMR) of a health system for patients with systemic autoimmune and scleritis diagnoses to determine the prevalence of both and which disorders had the highest relative risk of developing scleritis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The EMR was searched for scleritis and systemic inflammatory diagnoses in the past medical history and diagnosis tabs, and for associated disease specific laboratory values. The intersection of scleritis and systemic inflammatory conditions was assessed through searching both SNOMED Clinical Terminology and ICD-10 codes for diagnoses. The prevalence of each autoimmune disorder, scleritis prevalence, the percentage of patients with an autoimmune condition having scleritis, the percentage of patients with scleritis having an autoimmune condition; the relative risk (RR) of scleritis patients having a specific autoimmune disorder were calculated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 5.9 million charts were searched with autoimmune conditions identified in 148,993 patients. The most common autoimmune conditions overall were HLA-B27-associated diseases (<jats:italic>n<\/jats:italic>\u00a0=\u200926,680; prevalence 0.45%); rheumatoid arthritis (RA)(<jats:italic>N<\/jats:italic>\u00a0=\u200919,923; prevalence 0.34%). Conversely, 2702 patients were identified with scleritis (prevalence 0.05%), of which 31.4% had an associated autoimmune condition. Patients with RA represented the highest percentage of patients with an autoimmune condition having scleritis. Granulomatosis with polyangiitis (GPA) represented the highest the percentage of patients with scleritis having an autoimmune condition. Sjogrens was the third most common condition associated with scleritis- making up 4.5% of cases. An association with juvenile idiopathic arthritis (JIA) was seen in 0.3% of patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>While this is the largest retrospective review examining the association between autoimmune disease and scleritis, the findings are similar to prior studies with nearly a third of scleritis patients having an underlying autoimmune diagnosis. Limitations of the study included accurate chart coding; having laboratory results within the searchable EMR. Future research is needed to delineate associations of systemic disease with the anatomic location of scleritis using EMR.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-020-01769-3","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T20:05:26Z","timestamp":1609963526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Health system wide \u201cbig data\u201d analysis of rheumatologic conditions and scleritis"],"prefix":"10.1186","volume":"21","author":[{"given":"Meghan K.","family":"Berkenstock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"1769_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/bjo.60.3.163","volume":"60","author":"PG Watson","year":"1976","unstructured":"Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmology. 1976;60:163\u201391.","journal-title":"Br J Ophthalmology"},{"key":"1769_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/bjo.60.3.192","volume":"60","author":"DDM McGavin","year":"1976","unstructured":"McGavin DDM, Williamson J, Forrester JV, et al. Episcleritis and scleritis. A study of their clinical manifestation and association with rheumatoid arthritis. Br J Ophthalmol. 1976;60:192\u2013226.","journal-title":"Br J Ophthalmol"},{"key":"1769_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0161-6420(94)31325-X","volume":"101","author":"M Sainz de la Maza","year":"1994","unstructured":"Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389\u201396.","journal-title":"Ophthalmology"},{"key":"1769_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0161-6420(91)32269-3","volume":"98","author":"SJ Tuft","year":"1991","unstructured":"Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991;98:467\u201371.","journal-title":"Ophthalmology"},{"key":"1769_CR5","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","volume":"106","author":"PJ McCluskey","year":"1999","unstructured":"McCluskey PJ, Watson PG, Lightman S, Haybittle J, Restori M, Branley M. Posterior scleritis. Clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999;106:2380\u20136.","journal-title":"Ophthalmology"},{"key":"1769_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0161-6420(95)30970-0","volume":"102","author":"M Sainz dela Maza","year":"1995","unstructured":"Sainz dela Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995;102:687\u201392.","journal-title":"Ophthalmology"},{"key":"1769_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130:469\u201376.","journal-title":"Am J Ophthalmol"},{"key":"1769_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.survophthal.2004.04.008","volume":"49","author":"VL Perez","year":"2004","unstructured":"Perez VL, Chavala SH, Ahmed M, et al. Ocular manifestations and concepts of systemic vasculitides. Surv Ophthalmol. 2004;49:399\u2013418.","journal-title":"Surv Ophthalmol"},{"key":"1769_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","volume":"111","author":"EK Akpek","year":"2004","unstructured":"Akpek EK, Throne EJ, Qazi FA, Do DV, Jabs DA. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111:501\u20136.","journal-title":"Ophthalmology."},{"issue":"1","key":"1769_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","volume":"119","author":"M Sainz de la Maza","year":"2012","unstructured":"Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119(1):43\u201350.","journal-title":"Ophthalmology."},{"issue":"6","key":"1769_CR11","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ajo.2009.07.021","volume":"148","author":"VR Raiji","year":"2009","unstructured":"Raiji VR, Palestine AG, Parver DL. Scleritis and systemic disease association in a community-based referral practice. Am J Ophthalmol. 2009;148(6):946\u201350. https:\/\/doi.org\/10.1016\/j.ajo.2009.07.021 Epub 2009 Oct 17.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1769_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10384-019-00674-7","volume":"63","author":"A Yoshida","year":"2019","unstructured":"Yoshida A, Watanabe M, Okubo A, Kawashima H. Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis). Jpn J Ophthalmol. 2019;63(5):417\u201324.","journal-title":"Jpn J Ophthalmol"},{"issue":"7","key":"1769_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/ICO.0000000000000437","volume":"34","author":"AE Levitt","year":"2015","unstructured":"Levitt AE, McManus KT, McClellan AL, Davis JL, Goldhardt R, Galor A. Ocular inflammation in the setting of concomitant systemic autoimmune conditions in an older male population. Cornea. 2015;34(7):762\u20137.","journal-title":"Cornea."},{"issue":"19","key":"1769_CR14","first-page":"30134","volume":"S0002\u20139394","author":"JH Kempen","year":"2019","unstructured":"Kempen JH, Pistilli M, Begum H, Fitzgereals TD, Liesegand TL, Payal A, Zebardast N, Bhatt NP, Foster CS, Jabs DA, Levy-Clark GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE. Remission of non-infectious anterior scleritis: incidence and predictive factors. Am J Ophthalmol. 2019;S0002\u20139394(19):30134\u20135.","journal-title":"Am J Ophthalmol"},{"key":"1769_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/ceo.13761","volume":"48","author":"LP Thong","year":"2020","unstructured":"Thong LP, Rogers SL, Hart CT, Hall AJ, Lim LL. Epidemiology of episcleritis and scleritis in Urban Australia. Clin Exp Ophthalmol. 2020;48:757.","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"1769_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","volume":"10","author":"M Artifoni","year":"2014","unstructured":"Artifoni M, Rothschild PR, Br\u00e9zin A, Guillevin L, Pu\u00e9chal X. Ocular inflammatory diseases associated with rheumatoid arthritis. Nat Rev Rheumatol. 2014;10(2):108\u201316.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1769_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ Vander Weele","year":"2017","unstructured":"Vander Weele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268\u201374.","journal-title":"Ann Intern Med"},{"key":"1769_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s10384-010-0889-7","volume":"55","author":"JY Oh","year":"2011","unstructured":"Oh JY, Kim MK, Wee WR. Infliximab for progressive peripheral ulcerative keratitis in a patient with juvenile rheumatoid arthritis. Jpn J Ophthalmol. 2011;55:70\u20131.","journal-title":"Jpn J Ophthalmol"},{"issue":"12","key":"1769_CR19","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1016\/S0161-6420(99)90520-1","volume":"106","author":"RW Read","year":"1999","unstructured":"Read RW, Weiss AH, Sherry DD. Episcleritis in childhood. Ophthalmology. 1999;106(12):2377\u20139.","journal-title":"Ophthalmology."},{"key":"1769_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000101931","volume":"221","author":"A Anshu","year":"2007","unstructured":"Anshu A, Chee SP. Posterior scleritis and its association with HLA B27 haplotype. Ophthalmologica. 2007;221:275\u20138.","journal-title":"Ophthalmologica."},{"issue":"4","key":"1769_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/09273948.2016.1185527","volume":"25","author":"K Panthanapitoon","year":"2017","unstructured":"Panthanapitoon K, Dodds EM, Cunningham ET Jr, Rothova A. Clinical Spectrum of HLA-B27-associated ocular inflammation. Ocul Immunol Inflamm. 2017;25(4):569\u201376.","journal-title":"Ocul Immunol Inflamm"},{"key":"1769_CR22","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/ard.2004.027128","volume":"64","author":"K Ahmadi-Simab","year":"2005","unstructured":"Ahmadi-Simab K, Lamprecht P, Nolle B, et al. Successful treatment of refractory anterior scleritis in primary Sjogren\u2019s syndrome with rituximab. Ann Rheum Dis. 2005;64:1087\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1769_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clae.2011.10.002","volume":"35","author":"NR Bamrolia","year":"2012","unstructured":"Bamrolia NR, Arora R, Yadava U. Unusual presentation of a case of Sjogren\u2019s syndrome with neurological and ocular manifestation. Cont Lens Anterior Eye. 2012;35:85\u20138.","journal-title":"Cont Lens Anterior Eye"},{"key":"1769_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3341\/kjo.2011.25.4.275","volume":"25","author":"W Choi","year":"2011","unstructured":"Choi W, Lee SS, Park YG, et al. A case of necrotizing keratoscleritis in primary Sjogren\u2019s syndrome. Korean J Ophthalmol. 2011;25:275\u20137.","journal-title":"Korean J Ophthalmol"},{"issue":"1","key":"1769_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ophtha.2014.07.026","volume":"122","author":"EK Akpek","year":"2015","unstructured":"Akpek EK, Mathews P, Hahn S, Hessen M, Kim J, Grader-Beck T, Birnbaum J, Baer AN. Ocular and systemic morbidity in a longitudinal cohort of Sjogren syndrome. Ophthalmology. 2015 Jan;122(1):56\u201361.","journal-title":"Ophthalmology."}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01769-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-020-01769-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01769-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T21:36:06Z","timestamp":1609968966000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01769-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1769"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01769-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"7 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A waiver for consent was obtained from the Johns Hopkins Hospital IRB. This retrospective study was conducted without an individual chart review. No consent was required as no identifiable information was obtained. Only aggregate data were\u00a0used.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No consent is needed as the study obtained a waiver of consent and used only aggregate data without identifiable patient information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}